Back to Programme Overview Optimising survival in metastatic castration-resistant prostate cancer (mCRPC) Industry session by SANOFI GENZYME Friday 24 March 16:15 - 17:45 Location: Room London, North Hall (Level 1) Chair: B. Tombal, Brussels (BE) 16:15 - 16:20 Welcome and introduction B. Tombal, Brussels (BE) Webcast 16:20 - 16:40 Are we targeting prostate cancer heterogeneity in the right way? B. Tombal, Brussels (BE) Webcast 16:40 - 17:00 mCRPC in 2017 - Lessons from clinical trials and perspectives J. De Bono, Sutton (GB) Webcast 17:00 - 17:20 mCRPC in 2017 - From clinical trials to real-life practice S. Oudard, Paris (FR) Webcast 17:20 - 17:40 mCRPC in 2017 - A closer look to senior adults N. Mottet, Saint-Étienne (FR) Webcast 17:40 - 17:45 Discussion and closing remarks B. Tombal, Brussels (BE) Webcast